Aster, a tech-enabled pregnancy care platform, has secured $2.4 million in pre-seed funding to enhance maternal health services and expand clinic partnerships across the U.S.
Target Information
Aster is a technology-driven pregnancy care platform designed for both patients and clinical providers. The company has recently raised $2.4 million in pre-seed funding, which will be utilized to enhance its proprietary patient-facing application and clinician platform, as well as to expand its partnerships with clinics across the United States. Aster is committed to revolutionizing the technology that supports women’s health, providing software solutions that improve patient care and operational efficiency.
With its focus on maternal health, Aster aims to address the alarming rate of maternal mortality in the U.S., which is the highest among wealthier nations. By working closely with various clinics nationwide—from California to Texas, New York, Ohio, and Alabama—Aster is striving to create a supportive environment for expectant mothers and effectively manage pregnancy complications that are often preventable.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The maternal health sector in the United States is currently facing significant challenges, as highlighted by alarming statistics from the CDC indicating that up to 80% of pregnancy complications leading to maternal mortality are avoidable. T
Similar Deals
Dental Innovation Alliance VC Fund I, LP (DIA) → DentalBee
2025
2048 → Rondah AI
2025
Highline Beta → Flora Fertility
2024
Meridian Street Capital → Readout AI
2023
Insignum AgTech → Insignum AgTech
2023
Cornerstone VC and Cake Ventures
invested in
Aster
in 2024
in a Pre-Seed Stage deal
Disclosed details
Transaction Size: $2M